期刊文献+

可降解与非降解聚合物涂层雷帕霉素洗脱支架置入小型猪冠状动脉后的对比研究 被引量:5

A Comparative Study for the Safety and Efficiency in Sirolimus-Eluting Stents Coated With Biodegradable or Permanent Polymers in Porcine Coronary Artery
下载PDF
导出
摘要 目的:对比4种不同的生物可降解或非降解聚合物涂层的雷帕霉素洗脱支架(SES)置入健康小型猪冠状动脉后的安全性及有效性。方法:对2007-09至2009-07期间本研究组完成的采用4种不同涂层SES的动物实验资料进行分析,分为可降解的聚乳酸聚羟基乙酸共聚物(PLGA)涂层SES组(PLGA组)、可降解的聚左旋乳酸(PLLA)涂层SES组(PLLA组)、非降解的苯乙烯丁烯嵌段共聚物(SBS)涂层SES组(SBS组)和非降解的聚乙烯醋酸乙烯酯(EVAC)涂层SES组(EVAC组)。PLGA组包括4周观察终点的猪5只,另外3组包括4周观察终点的猪各4只。每只猪于左前降支和右冠状动脉各置入同种支架1枚。至观察终点时复查冠状动脉造影并处死取材,通过形态学方法观察血管壁炎症及内膜增生情况。结果:4周时EVAC组有3例标本血管壁大量淋巴细胞和嗜酸细胞浸润,形成炎症肉芽肿,而PLGA组、PLLA组和SBS组无明显炎症反应。PLGA组、PLLA组和SBS组平均炎症细胞密度,残余管腔直径,残余管腔面积,内弹力板围绕面积,外弹力板围绕面积均显著小于EVAC组,差异有统计学意义(P均<0.05),而PLGA组、PLLA组和SBS组之间差异无统计学意义(P均>0.05)。各组间在反映内膜增生的指标(平均内膜厚度、新生内膜面积、面积狭窄百分比)上差异均无统计学意义(P均>0.05)。各组均无支架内狭窄(面积狭窄百分比≥50%)发生。结论:这4种采用不同涂层的SES支架均可以显著抑制健康小型猪冠状动脉支架置入术后4周时的内膜增生。采用可降解的PLGA和PLLA涂层的SES有良好的组织相容性,而非降解的EVAC涂层SES有较重的炎症反应。 Objective: To compare the safety and efficiency in 4 kinds of sirolimus-eluting stem (SES) coated with different biodegradable or permanent polymers in healthy porcine coronary artery model. Methods : We performed a preclinical study in 4 kinds of SES coated with different polymers in healthy porcine coronary artery from September 2007 to July 2009 in our hospital. SES were coated with biodegradable polylactic acid-co-polyglycolic acid polymer (PLGA group) and poly-L-lactic acid polymer (PLLA group) ; with permanent styrene-butylene-styrene polymer (SBS group) and ethylene-vinyl acetate copolymer (EVAC group). In PLGA group,n = 5, and in the other three groups,n =4,respectively. Two same stents were implanted into the same animal, one in left anterior descending artery, the other in right coronary artery for 4 weeks. Coronary angiography was performed at the end point of the treatment, and the neointimal proliferation and inflammation were examined by histomorphometric measurements in each animal. Results: At 4-week time point,extensive inflammation with granulomatous reaction including eosinophils and lymphocytes infiltration was developed in 3 animals in EVAC group,while no obvious inflammatory reaction was observed in the other 3 groups. The average inflammatory cell density in stented artery wall was significantly higher in EVAC group than that in the other 3 groups,P 〈 0.05 respectively, and no statistical differences were found among the other 3 groups, P 〉 0. 05. The similar level of neointimal proliferation parameters as the average of neointimal thickness, neointimal area and the percentage area stenosis were found in all 4 experimental groups. No in-stent stenosis occurred in the experimental animals. Conclusion: Our study presented that 4 kinds of SES could significantly inhibit the neointimal proliferation in 4 weeks of stent implantation in healthy porcine coronary artery model. SES coated with biodegradable PLGA and PLLA polymers had the better biocompatibility; while with permanent EVAC polymers might cause severe inflammatory response in some cases.
出处 《中国循环杂志》 CSCD 北大核心 2010年第5期387-390,共4页 Chinese Circulation Journal
关键词 药物洗脱支架 雷帕霉素 聚合物 生物可降解 Drug-eluting stent Sirolimus Polymer Biodegradable
  • 相关文献

参考文献5

二级参考文献25

  • 1郑金刚,高润霖,程树军,王春宁,钱杰,阮英茆,王清峙,袁晋青,孟亮,乔树宾,陈纪林.可降解雷帕霉素洗脱支架对猪冠状动脉支架置入术后内膜增生的影响[J].中国循环杂志,2004,19(3):190-193. 被引量:9
  • 2徐卫亭,霍勇,陈明,李拥军,洪涛,高炜.雷帕霉素涂层支架对支架内早期再狭窄的预防[J].临床心血管病杂志,2004,20(11):677-679. 被引量:3
  • 3邱洪,高润霖,唐智荣,孟亮,兆恒,阮英卯,赵红,杨跃进,陈纪林,陈在嘉.Mytrolimus药物洗脱支架预防支架内再狭窄的实验研究[J].中华心血管病杂志,2005,33(6):561-564. 被引量:15
  • 4付剑云,苏又苏,吴京兰,方红城,王执兵,谢培益,陈少源.冠脉支架术前、术后血清sCD40L水平与再狭窄的关系[J].实用全科医学,2007,5(3):193-195. 被引量:7
  • 5Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349(14) : 1315-1325.
  • 6Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med, 2004, 350(3) :221-231.
  • 7Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med, 2007, 356 (10) :998-1008.
  • 8Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol, 2007, 27 (7) : 1500-1510.
  • 9Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation, 104(4):473-479.
  • 10Klugherz BD, Llanos G, Lieuallen W, et al. Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent. Coron Artery Dis, 2002, 13(3) :183-188.

共引文献55

同被引文献53

  • 1邱洪,高润霖,唐智荣,孟亮,兆恒,阮英卯,赵红,杨跃进,陈纪林,陈在嘉.Mytrolimus药物洗脱支架预防支架内再狭窄的实验研究[J].中华心血管病杂志,2005,33(6):561-564. 被引量:15
  • 2陈丹,吕安林,苑媛,李丹.药物涂层支架研究进展[J].心脏杂志,2006,18(5):591-594. 被引量:9
  • 3Lonvard Y, Thomas M, Dzavik V, et al. Classification of coronary artery bifureation lesions and treatments:time for a consensusi [ J ]. Catheter Cardiovasc Interv, 2008, 71(2) :175-183.
  • 4Moses JW, Leon MB, Popma J J, et al. Sirolimus - elutiog stents versus standard stents in patients with stenosis in a native coronary artery [ J ]. N Engl J Med,2003,349 (14) :1315-1323.
  • 5Colombo A, Iakovou I. Ten years of advancements in in- terventional cardiology [ J ]. J Endovasc Ther, 2004,11 Suppl 2:Ⅱ 10-18.
  • 6Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions:two stents versus one stent immediate and follow - up results [ J ]. J Am Coil Cardiol, 2000,35 ( 5 ) : 1145-1151.
  • 7Holmes DR Jr, Leon MB, Moese JW, et al. Analysis of 1 year clinical outcomes in the SIRIUS trail:a randomized trail of a sirolimus - eluting stent versus a standard stent in patients at high risk for coronary restenosis [ J ]. Cir- culation ,2004,109 ( 5 ) :634-640.
  • 8Lemos PA, Serruys PW, van Domburg RT, et al. Unre- stricted utilization of sirolimus - eluting stents compared with conventional bare stent implantation in the 'real word': the Rapamycin -Eluting Stent Evaluated At Rotterdam Cradiology Hospital (RESEARCH) registry [J]. Circluation, 2004, 109(2) :190-195.
  • 9Virmani R, Guagliumi G, Farb A, et al. Localized hyper- sensitivity and late coronary thrombosis secondary to a sirolimus -eluting stent:Should we be cautions[ J]. Cir- culation ,2004,109 (6) :701-705.
  • 10Tudor C, Poemer MD, Stefan Kralev, at al. Natural histo- ry of small and medium - sized side branches after cor- nary stent implantation [ J ]. Am Heart J,2002,143 (4) : 627-635.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部